+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-05-19Number of Pages: 119

Respiratory Disease Testing Market (By Tests - Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and Other Tests); (By End-User - Hospitals, Physician Offices and Clinical Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Secondary Research

      1.3.2 Primary Research

      1.3.3 Models

      1.3.4 Assumptions

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Respiratory Disease Testing Market (2013 & 2022)

2.2 Global Respiratory Disease Testing Market, by Tests, 2013 (USD Million)

2.3 Comparative Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 and 2022 (Value %)

 

Chapter 3 Market Overview

3.1 Overview

3.2 Value Chain Analysis

3.3 Market Drivers

      3.3.1 Increasing prevalence of respiratory diseases

      3.3.2 Growing geriatric population propels the uptake of respiratory disease testing products

      3.3.3 Technological advancements boost demand for respiratory disease testing products

3.4 Restraints

      3.4.1 Low adoption rate of digital radiography systems and advanced spirometers

3.5 Opportunities

      3.5.1 Capitalizing on the potential presented by emerging markets in Asia-Pacific

3.6 Regulatory Framework

3.7 Porter’s Five Forces Analysis: Global Respiratory Disease Testing Market

      3.7.1 Bargaining power of suppliers

      3.7.2 Bargaining power of buyers

      3.7.3 Threat of substitutes      

      3.7.4 Threat of new entrants

      3.7.5 Competitive rivalry

3.8 Market Attractiveness Analysis: Global Respiratory Disease Testing Market, by Geography

      3.9.1 Market Share Analysis, by Key Players: Global Respiratory Disease Testing Market, 2013 (Value %)

 

Chapter 4 Global Respiratory Disease Testing Market, by Tests

4.1 Overview

      4.1.1 Global Respiratory Disease Testing Market Revenue, by Tests, 2012 – 2022 (USD Million)

4.2 Imaging Tests

      4.2.1 Global Imaging Test Market Revenue, 2012 – 2022 (USD Million)

4.3 Spirometry

      4.3.1 Global Spirometry Test Market Revenue, 2012 – 2022 (USD Million)

4.4 Peak Flow Test

      4.4.1 Global Peak Flow Test Market Revenue, 2012 – 2022 (USD Million)

4.5 Blood Gas Test

      4.5.1 Global Blood Gas Test Market Revenue, 2012 – 2022 (USD Million)

4.6 Lung Volume Test

      4.6.1 Global Lung Volume Test Market Revenue, 2012 – 2022 (USD Million)

4.7 Other Tests (Exercise, Gas transfer, Bronchoscopy, Thoracoscopy, etc.)

      4.7.1 Global Other Tests Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 5 Global Respiratory Disease Testing Market, by End-User

5.1 Overview      

      5.1.1 Global Respiratory Disease Testing Market Revenue, by End-User, 2012 – 2022 (USD Million)

5.2 Hospitals

      5.2.1 Global Hospitals End-User Market Revenue, 2012 – 2022 (USD Million)

5.3 Physician Offices

      5.3.1 Global Physician Offices End-User Market Revenue, 2012 – 2022 (USD Million)

5.4 Clinical Laboratories

      5.4.1 Global Clinical Laboratories End-User Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 6 Global Respiratory Disease Testing Market, by Geography

6.1 Overview

      6.1.1 Global Respiratory Disease Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

6.2 North America

      6.2.1 North America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

      6.2.2 U.S.

              6.2.2.1 U.S. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.2.3 Canada

              6.2.3.1 Canada Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.3 Europe

      6.3.1 Europe Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

      6.3.2 U.K.

             6.3.2.1 U.K. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.3.3 Germany

             6.3.3.1 Germany Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.3.4 Rest of Europe

             6.3.4.1 Rest of Europe Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.4 Asia Pacific

      6.4.1 Asia Pacific Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

      6.4.2 Japan

              6.4.2.1 Japan Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.4.3 China

              6.4.3.1 China Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.4.4 Rest of Asia Pacific

              6.4.4.1 Rest of APAC Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.5 Latin America

      6.5.1 Latin America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)      

      6.5.2 Brazil

              6.5.2.1 Brazil Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.5.3 Mexico

              6.5.3.1 Mexico Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.5.4 Rest of Latin America 

              6.5.4.1 Rest of LATAM Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.6 Middle East North Africa (MENA)

      6.6.1 Middle East North Africa Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

      6.6.2 Saudi Arabia

              6.6.2.1 Saudi Arabia Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.6.3 UAE

             6.6.3.1 UAE Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.6.4 Rest of MENA

             6.6.4.1 Rest of MENA Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.7 Rest of the World

      6.7.1 Rest of the World Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 7 Recommendations

7.1 Market Strategy for Success

      7.1.1 Mergers and acquisitions for market expansion

      7.1.2 Emphasize on increasing affordability of modern imaging systems

      7.1.3 Investing in emerging markets

 

Chapter 8 Company Profiles

8.1 CareFusion Corporation

      8.1.1 Company Overview

      8.1.2 Financial Overview

      8.1.3 Product Portfolio

      8.1.4 Business Strategies

      8.1.5 Recent Developments

8.2 Carestream Health, Inc.

      8.2.1 Company Overview

      8.2.2 Financial Overview

      8.2.3 Product portfolio

      8.2.4 Business Strategies

      8.2.5 Recent Developments

8.3 COSMED

      8.3.1 Company Overview

      8.3.2 Financial Overview

      8.3.3 Product Portfolio

      8.3.4 Business Strategies

      8.3.5 Recent Developments

8.4 Futuremed America, Inc.

      8.4.1 Company Overview

      8.4.2 Financial Overview

      8.4.3 Product Portfolio

      8.4.4 Business Strategies

8.5 GE Healthcare

      8.5.1 Company Overview

      8.5.2 Financial Overview

      8.5.3 Product Portfolio

      8.5.4 Business Strategies

      8.5.5 Recent Developments

8.6 MGC Diagnostics Corporation

      8.6.1 Company Overview

      8.6.2 Financial Overview

      8.6.3 Product Portfolio

      8.6.4 Business Strategies

      8.6.5 Recent Developments

8.7 ndd Medical Technologies, Inc.

      8.7.1 Company Overview

      8.7.2 Financial Overview

      8.7.3 Product Portfolio

      8.7.4 Business Strategies

      8.7.5 Recent Developments

8.8 NIHON KOHDEN CORPORATION

      8.8.1 Company Overview

      8.8.2 Financial Overview

      8.8.3 Product Portfolio

      8.8.4 Business Strategies

      8.8.5 Recent Developments

8.9 Perkin Elmer, Inc.

      8.9.1 Company Overview

      8.9.2 Financial Overview

      8.9.3 Product Portfolio

      8.9.4 Business Strategies

      8.9.5 Recent Developments

8.10 Philips Healthcare

      8.10.1 Company Overview

      8.10.2 Financial Overview

      8.10.3 Product Portfolio

      8.10.4 Business Strategies

      8.10.5 Recent Developments

8.11 SDI Diagnostics

      8.11.1 Company Overview

      8.11.2 Financial Overview

      8.11.3 Product Portfolio

      8.11.4 Business Strategies

8.12 Siemens Healthcare

      8.12.1 Company Overview

      8.12.2 Financial Overview

      8.12.3 Product Portfolio

      8.12.4 Business Strategies

      8.12.5 Recent Developments

8.13 Smiths Medical

      8.13.1 Company Overview

      8.13.2 Financial Overview

      8.13.3 Product Portfolio

      8.13.4 Business Strategies

      8.13.5 Recent Developments

List of Figures

 

FIG. 1 Respiratory Disease Testing : Market Segmentation

FIG. 2 Global Respiratory Disease Testing Market, by Tests, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 & 2022 (Value %)

FIG. 4 Value Chain Analysis of the Respiratory Disease Testing Market

FIG. 5 Porter’s Five Forces Analysis: Global Respiratory Disease Testing Market

FIG. 6 Market Attractiveness Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 Value (%)

FIG. 7 Market Share Analysis, by Key Players: Global Respiratory Disease Testing Market, 2013 (Value %)

FIG. 8 Global Imaging Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 9 Global Spirometry Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 10 Global Peak Flow Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 11 Global Blood Gas Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 12 Global Lung Volume Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 13 Global Other Tests Market Revenue, 2012 – 2022 (USD Million)

FIG. 14 Global Hospitals End-User Market Revenue, 2012 – 2022 (USD Million)

FIG. 15 Global Physician Offices End-User Market Revenue, 2012 – 2022 (USD Million)

FIG. 16 Global Clinical laboratories End-User Market Revenue, 2012 – 2022 (USD Million)

FIG. 17 U.S. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 18 Canada Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 19 U.K. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 20 Germany Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 21 Rest of Europe Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 22 Japan Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 23 China Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 24 Rest of APAC Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 25 Brazil Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 26 Mexico Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 27 Rest of LATAM Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 28 Saudi Arabia Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 29 UAE Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 30 Rest of MENA Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 31 Rest of the World Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 32 CareFusion Corporation: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 33 Carestream Health, Inc.: Annual Revenue,  2011 – 2013 (USD Million)

FIG. 34 GE Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 35 MGC Diagnostic Corporation: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 36 NIHON KOHDEN CORPORATION: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 37 PerkinElmer Inc.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 38 Philips Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 39 Siemens Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 40 Smiths Medical: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Respiratory Disease Testing Market (2013 & 2022)

TABLE 3 Global Respiratory Disease Testing Market Revenue, by Tests, 2012 – 2022 (USD Million)

TABLE 4 Global Respiratory Disease Testing Market Revenue, by End-User, 2012 – 2022 (USD Million)

TABLE 5 Global Respiratory Disease Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

TABLE 6 North America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 7 Europe Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 8 Asia Pacific Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 9 Latin America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 10 Middle East North Africa Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)


 
 
Back To Top